CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹13,454 Cr | ₹12,689 Cr | ₹11,732 Cr | ₹11,925 Cr | ₹11,628 Cr |
What is the latest Total Non-Current Assets ratio of CIPLA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹13,454 Cr |
| Mar2024 | ₹12,689 Cr |
| Mar2023 | ₹11,732 Cr |
| Mar2022 | ₹11,925 Cr |
| Mar2021 | ₹11,628 Cr |
How is Total Non-Current Assets of CIPLA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,454 Cr | 6.03 | |
| Mar2024 | ₹12,689 Cr | 8.16 | |
| Mar2023 | ₹11,732 Cr | -1.62 | |
| Mar2022 | ₹11,925 Cr | 2.55 | |
| Mar2021 | ₹11,628 Cr | - | |
Compare Total Non-Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,414.8 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
| MANKIND PHARMA | ₹85,533.2 Cr | -0.9% | -5.8% | -18.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.3% |
-8.5% |
-7.3% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses